Dr. Panos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 Piedmont Avenue
Suite 4000
Cincinnati, OH 45219Phone+1 513-475-8523Fax+1 513-475-7327
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990
- University of MarylandResidency, Internal Medicine, 1983 - 1987
- The Warren Alpert Medical School of Brown UniversityClass of 1983
Certifications & Licensure
- OH State Medical License 2004 - 2026
- PA State Medical License 1997 - 2004
- IL State Medical License 1991 - 1999
- CO State Medical License 1990 - 1993
- MD State Medical License 1986 - 1987
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation.Paraschos Archontakis Barakakis, Adam Wolfe, Andrei Schwartz, Gabriel J Hernandez Romero, Vipul Gidwani
ERJ Open Research. 2024-11-01 - Future Considerations and Areas for Innovation for Pulmonary Rehabilitation in Chronic Obstructive Lung Disease Patients.John W Connell, Scott A Humason, Ralph J Panos, Robert Burkes
Seminars in Respiratory and Critical Care Medicine. 2024-10-01 - 1 citationsAssociation of interactions between tele-critical care and bedside with length of stay and mortality.Amy Mj O'Shea, Heather S Reisinger, Ralph Panos, Matt Goede, Spyridon Fortis
Journal of Telemedicine and Telecare. 2024-07-01
Press Mentions
- Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung InfectionsApril 6th, 2018
- Veterans Affairs Hospital Introduces New Tele-ICU TechnologyMarch 28th, 2018
- Arch Biopartners’ Lead Anti-Bacterial Drug Candidate AB569 to Enter Investigator-Sponsored Phase I Human TrialApril 13th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: